首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Breast cancer-targets and therapy

缩写:

ISSN:1179-1314

e-ISSN:1179-1314

IF/分区:3.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引704
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Min Xiong,Quanjun Yang,Le Cheng et al. Min Xiong et al.
Objective: To clarify the expression and clinical significance of LINC01128 in triple-negative breast cancer (TNBC), investigate whether it regulates the biological behaviors of TNBC cells by targeting miR-32-5p via the c...
Lucia Mangone,Francesco Marinelli,Isabella Bisceglia et al. Lucia Mangone et al.
Purpose: Axillary surgery in breast cancer has progressively evolved over the past decades toward less invasive approaches. Patients and methods: ...
Zeliha Birsin,Ali Kaan Güren,Vali Aliyev et al. Zeliha Birsin et al.
Background: Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) combined with endocrine therapy represent the standard first-line treatment for hormone receptor-positive (HR+), HER2-negative metastatic breast cancer. However...
Guy Ilunga Nday,Manix Ilunga Banza,Anastasie Ngalula Umpungu et al. Guy Ilunga Nday et al.
Background: Breast cancer is a heterogeneous disease and HER2 overexpression identifies a subgroup of tumors associated with aggressive behavior and targeted therapy response. Although HER2 expression has been widely stud...
Akira Tsunoda,Toshiro Mizuno,Shiro Nakamori et al. Akira Tsunoda et al.
Purpose: The incidence of trastuzumab-related cardiotoxicity is low among patients receiving regimens that do not include anthracyclines. We aimed to examine whether cardiac monitoring during paclitaxel and trastuzumab th...
Joshua Behar,Christine Shiang,Deniz Nesli Dolcen et al. Joshua Behar et al.
Purpose: Analyses of patients with early-stage, treatment-naïve triple-negative breast cancer (TNBC) have demonstrated that high glucocorticoid receptor (GR) expression in primary tumors is associated with poor prognosis...
Baha Sharaf,Alaa Seif,Hira Bani Hani et al. Baha Sharaf et al.
Purpose: Trastuzumab-based neoadjuvant therapy (NAT) is standard for HER2-positive breast cancer (HER2+ BC). The TCHP regimen (docetaxel, carboplatin, trastuzumab, pertuzumab) demonstrated efficacy in clinical trials; how...
Sushuang Ma,Yanqiu Huang,Qingyan Yang et al. Sushuang Ma et al.
Objective: To investigate the correlation between plasma exosomal circular RNA (circRNA) (non-invasive, dynamically monitorable) and lymph node metastasis following neoadjuvant chemotherapy in breast cancer and highlight ...
Jiahui Wu,Wang Yi,Mengting Liu et al. Jiahui Wu et al.
Background: Although IFI44 is recognized for its crucial role in autoimmune disorders, its function in breast cancer (BC) remains unclear. This study aimed to investigate the immune-related and prognostic significance of ...
Qian Zhang,Shan Wang,Jiajia Zhang et al. Qian Zhang et al.
Purpose: This study aims to evaluate the effectiveness of a supportive intervention program designed based on Existence-Relatedness-Growth theory and the Supportive Care Needs Framework in reducing unmet needs among breas...